World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
16286
World Ranking
3297
National Ranking
152

Overview

Erika Vacchelli is affiliated with Université Paris Cité in France. Their research focuses primarily on biochemistry, genetics and molecular biology, medicine, and immunology and microbiology, with a total of 15, 14, and 12 publications respectively in these fields.

The scientist's work extensively covers several specialized subfields including immunology, molecular biology, oncology, pharmacology, and infectious diseases. Key topics addressed in their research include S100 proteins and annexins, interferon and immune responses, immune response and inflammation, immunotherapy and immune responses, cancer immunotherapy and biomarkers, biomarkers in disease mechanisms, and cannabis and cannabinoid research.

Erika Vacchelli has contributed to various academic journals, with a notable concentration of publications in OncoImmunology, totaling 10 papers. Other venues where their work appears include Cancer Discovery, Cell Death and Differentiation, Cell Death Discovery, and Neural Computing and Applications.

Their frequent coauthors in research collaborations are:

  • Guido Kroemer (15 collaborations)
  • Julie Le Naour (12 collaborations)
  • Laurence Zitvogel (5 collaborations)
  • Lorenzo Galluzzi (5 collaborations)
  • Allan Sauvat (5 collaborations)

Recent publications authored or coauthored by Erika Vacchelli include:

  • "Trial watch: STING agonists in cancer therapy", 2020, OncoImmunology
  • "Trial watch: TLR3 agonists in cancer therapy", 2020, OncoImmunology
  • "Trial watch: IDO inhibitors in cancer therapy", 2020, OncoImmunology
  • "Trial Watch: experimental TLR7/TLR8 agonists for oncological indications", 2020, OncoImmunology
  • "A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency", 2020, Cancer Discovery

This body of work reflects an emphasis on cancer immunotherapy and the development of immune modulatory strategies targeting toll-like receptors and other agents involved in oncological therapies.

Best Publications

  • Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.

    Mickaël Michaud;Mickaël Michaud;Mickaël Michaud;Isabelle Martins;Isabelle Martins;Isabelle Martins;Abdul Qader Sukkurwala;Abdul Qader Sukkurwala;Abdul Qader Sukkurwala;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian

  • Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    Antonella Sistigu;Takahiro Yamazaki;Erika Vacchelli;Kariman Chaba

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.

    Yuting Ma;Yuting Ma;Yuting Ma;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian;Stephen R. Mattarollo;Takahiro Yamazaki;Takahiro Yamazaki;Takahiro Yamazaki

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

    Federico Pietrocola;Federico Pietrocola;Jonathan Pol;Erika Vacchelli;Erika Vacchelli;Shuan Rao

  • Regulation of Autophagy by Cytosolic Acetyl-Coenzyme A

    Guillermo Mariño;Federico Pietrocola;Tobias Eisenberg;Yongli Kong

  • Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death

    Laurie Menger;Erika Vacchelli;Erika Vacchelli;Erika Vacchelli;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian;Isabelle Martins;Isabelle Martins;Isabelle Martins

  • Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

    Erika Vacchelli;Yuting Ma;Elisa E. Baracco;Antonella Sistigu

  • Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

    Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert

  • Mitochondrial gateways to cancer.

    Lorenzo Galluzzi;Eugenia Morselli;Eugenia Morselli;Oliver Kepp;Oliver Kepp;Ilio Vitale;Ilio Vitale

  • Trial watch: IDO inhibitors in cancer therapy

    Erika Vacchelli;Fernando Aranda;Alexander Eggermont;Catherine Sautès-Fridman

  • Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy.

    Jonathan Pol;Erika Vacchelli;Fernando Aranda;Francesca Castoldi

  • Regulation of autophagy by stress-responsive transcription factors.

    Federico Pietrocola;Valentina Izzo;Mireia Niso-Santano;Mireia Niso-Santano;Erika Vacchelli;Erika Vacchelli

  • Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

    Laura Senovilla;Erika Vacchelli;Jerome Galon;Sandy Adjemian

  • Crizotinib-induced immunogenic cell death in non-small cell lung cancer

    Peng Liu;Liwei Zhao;Jonathan Pol;Sarah Levesque

  • Trial watch

    Unknown

  • Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.

    Erika Vacchelli;Lorenzo Galluzzi;Alexander Eggermont;Wolf Hervé Fridman

  • Trial watch: Chemotherapy with immunogenic cell death inducers.

    Erika Vacchelli;Laura Senovilla;Alexander Eggermont;Wolf Hervé Fridman

  • Trial watch: Oncolytic viruses for cancer therapy

    Erika Vacchelli;Alexander Eggermont;Catherine Sautès-Fridman;Jérôme Galon

  • Trial watch: Dendritic cell-based interventions for cancer therapy.

    Erika Vacchelli;Ilio Vitale;Alexander Eggermont;Wolf Hervé Fridman

Frequent Co-Authors

Guido Kroemer
Guido Kroemer Université Paris Cité
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Oliver Kepp
Oliver Kepp Institut Gustave Roussy
Isabelle Martins
Isabelle Martins Inserm : Institut national de la santé et de la recherche médicale
Laura Senovilla
Laura Senovilla University of Valladolid
Alexander M.M. Eggermont
Alexander M.M. Eggermont Institut Gustave Roussy
Federico Pietrocola
Federico Pietrocola Karolinska Institute
Yuting Ma
Yuting Ma University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring allied health and nursing pathways can be a practical step. Programs such as accredited lpn programs easy to get into offer accessible entry points into healthcare, providing foundational knowledge useful in immunology-related settings.

Moving forward, one might consider advancing to roles like nurse practitioners. The easiest nurse practitioner degree programs provide streamlined options for registered nurses seeking graduate-level qualifications with flexibility and supportive curricula.

For those drawn to mental health, specifically the intersection with immunological factors, exploring best psychiatric mental health nurse practitioner programs online can be invaluable. These programs often offer excellent clinical placement rates to gain real-world experience.

Cost can be a concern, so researching cheapest psychiatric nurse practitioner programs enables prospective students to find budget-friendly options without compromising quality.

Overall, these related online degrees open diverse career pathways that complement immunology knowledge, combining scientific understanding with practical healthcare skills.

Best Scientists Citing Erika Vacchelli

Trending Scientists

Recently Published Articles